Leadership

NCCN Board of Directors

The NCCN Board of Directors is comprised of two representatives from each NCCN Member Institution who share in NCCN's mission to define and advance quality, effective, equitable, and accessible cancer care and prevention so all people can live better lives.

• Matt Kalaycio, MD, FACP / Chair
  Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute

• Christopher H. Lieu, MD / Vice-Chair
  University of Colorado Cancer Center

• Patrick J. O'Brien, MBA / Treasurer
  Fox Chase Cancer Center

• Maria M. Gonzalez, MPH, BS / Secretary
  Stanford Cancer Institute

• Edwin P. Alyea III, MD
  Duke Cancer Institute

• Sachin M. Apte, MD, MBA, MS
  Huntsman Cancer Institute at the University of Utah

• Carlos L. Arteaga, MD
  UT Southwestern Simmons Comprehensive Cancer Center

• James E. Bachman, MPA
  Johns Hopkins Kimmel Cancer Center

• Al B. Benson III, MD, FASCO, FACP
  Robert H. Lurie Comprehensive Cancer Center of Northwestern University

• Rondeep Brar, MD
  Stanford Cancer Institute

• Laurel Bray-Hanin, MA
  UCSF Helen Diller Family Comprehensive Cancer Center

• Craig A. Bunnell, MD, MBA, MPH
  Dana-Farber/Brigham and Women's Cancer Center | Mass General Cancer Center

• Rebecca L. Caires, MBA
  Robert H. Lurie Comprehensive Cancer Center of Northwestern University

• William E. Carson, MD
  The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute

• Peter Connor, MS
  University of Wisconsin Carbone Cancer Center

• Gena Cook
  NCCN Foundation Board of Directors

• David T. Cooke, MD, FACS
  UC Davis Comprehensive Cancer Center

• Nancy E. Davidson, MD
  Fred Hutchinson Cancer Center

• Gina Dayton, MPA
  UC Davis Comprehensive Cancer Center

• Jordan M. DeMoss, MSHA
  O'Neal Comprehensive Cancer Center at UAB

• Amy E. DeZern, MD, MHS
  Johns Hopkins Kimmel Cancer Center

• Timothy R. Donahue, MD
  UCLA Jonsson Comprehensive Cancer Center

• Timothy J. Eberlein, MD, FACS
  Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine

• Stephen B. Edge, MD, FASCO, FACS
  Roswell Park Comprehensive Cancer Center

• Steven J. Frank, MD
  The University of Texas MD Anderson Cancer Center

• Laura W. Goff, MD, MSCI, MMHC
  Vanderbilt-Ingram Cancer Center

• Ayad Hamdan, MD
  UC San Diego Moores Cancer Center

• Barbara A. Jagels, RN, MHA, CPHQ
  UCLA Jonsson Comprehensive Cancer Center

• Jennifer Kennedy-Stovall
  Duke Cancer Institute

• Kris M. Kipp, MSN, RN
  The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute

• Timothy Kubal, MD, MBA
  Moffitt Cancer Center

• Michael R. Kuettel, MD, PhD, MBA
  Roswell Park Comprehensive Cancer Center

• Kelvin P. Lee, MD
  Indiana University Melvin and Bren Simon Comprehensive Cancer Center

• Ashley B. Lee
  City of Hope National Medical Center

• Christina J. Longnecker, BSN, MBA, JD, RN
  Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine

• Cynthia McCollum, MBA
  Memorial Sloan Kettering Cancer Center

• Brittany McCreery, MD, MBA
  Fred Hutchinson Cancer Center

• Katie McGill, MSM
  Indiana University Melvin and Bren Simon Comprehensive Cancer Center

• Robert R. McWilliams, MD, MSc, MSHA
  Mayo Clinic Comprehensive Cancer Center

• David B. Miller, MBA
  Abramson Cancer Center at the University of Pennsylvania

• Donald F. Milligan, MBA
  Huntsman Cancer Institute at the University of Utah

• Todd M. Morgan, MD
  University of Michigan Rogel Cancer Center

• Lisle M. Nabell, MD
  O'Neal Comprehensive Cancer Center at UAB

• Alberto S. Pappo, MD
  St. Jude Children's Research Hospital/The University of Tennessee Health Science Center

• David G. Pfister, MD
  Memorial Sloan Kettering Cancer Center

• Lori C. Pickens, MHA
  Yale Cancer Center/Smilow Cancer Hospital

• Elizabeth R. Plimack, MD, MS
  Fox Chase Cancer Center

• Mitchell C. Posner, MD, FACS
  The UChicago Medicine Comprehensive Cancer Center

• Ravi Salgia, MD, PhD
  City of Hope National Medical Center

• Theresa Sberna, MPH
  Vanderbilt-Ingram Cancer Center

• Bryan J. Schneider, MD
  University of Michigan Rogel Cancer Center

• Richard D. Schulick, MD, MBA, FACS
  University of Colorado Cancer Center

• David Shibata, MD, FACS, FASCRS
  St. Jude Children's Research Hospital/The University of Tennessee Health Science Center

• Diane Simeone, MD
  UC San Diego Moores Cancer Center

• Kyle F. Skiermont, PharmD
  Fred & Pamela Buffett Cancer Center

• Beth A. Souza, MS
  Dana-Farber/Brigham and Women's Cancer Center | Mass General Cancer Center

• Philippe E. Spiess, MD, MS, FACS, FRCS
  Moffitt Cancer Center

• Jolene Summer Bolster
  Mayo Clinic Comprehensive Cancer Center

• Kyle A. Taylor, MHSA, CPHQ
  UT Southwestern Simmons Comprehensive Cancer Center

• Theodoros Teknos, MD
  Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute

• Alan P. Venook, MD
  UCSF Helen Diller Family Comprehensive Cancer Center

• Robert H. Vonderheide, MD, DPhil
  Abramson Cancer Center at the University of Pennsylvania

• Julie M. Vose, MD, MBA
  Fred & Pamela Buffett Cancer Center

• Lauren Wall, MS
  The UChicago Medicine Comprehensive Cancer Center

• Ronald S. Walters, MD, MBA, MHA, MS
  The University of Texas MD Anderson Cancer Center

• Lee G. Wilke, MD, FACS
  University of Wisconsin Carbone Cancer Center

• Eric P. Winer, MD
  Yale Cancer Center/Smilow Cancer Hospital

Executive Committee

• Matt Kalaycio, MD, FACP / Chair
  Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute

• Al B. Benson III, MD, FACP, FASCO
  Robert H. Lurie Comprehensive Cancer Center of Northwestern University

• Nancy E. Davidson, MD
  Fred Hutchinson Cancer Center

• Laura W. Goff, MD, MMHC, MSCI
  Vanderbilt-Ingram Cancer Center

• Maria M. Gonzalez, MPH, BS
  Stanford Cancer Institute

• Barbara A. Jagels, RN, MHA, CPHQ
  UCLA Jonsson Comprehensive Cancer Center

• Christopher H. Lieu, MD
  University of Colorado Cancer Center

• Patrick J. O'Brien, MBA
  Fox Chase Cancer Center

• Lauren Wall, MS
  The UChicago Medicine Comprehensive Cancer Center

• Ronald S. Walters, MD, MBA, MS, MHA
  The University of Texas MD Anderson Cancer Center

Finance Committee

• Patrick J. O'Brien, MBA / Chair
  Fox Chase Cancer Center

• James E. Bachman, MPA
  Johns Hopkins Kimmel Cancer Center

• Jordan M. DeMoss, MSHA
  O'Neal Comprehensive Cancer Center at UAB

• Katie McGill, MSM
  Indiana University Melvin and Bren Simon Comprehensive Cancer Center

• Robert R. McWilliams, MD, MSHA, MSc
  Mayo Clinic Comprehensive Cancer Center

Governance Committee

• Christopher H. Lieu, MD / Chair
  University of Colorado Cancer Center

• Timothy J. Eberlein, MD, FACS
  Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine

• Maria M. Gonzalez, MPH, BS
  Stanford Cancer Institute

• Matt Kalaycio, MD, FACP
  Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute

• Ashley B. Lee
  City of Hope National Medical Center

• Kelvin P. Lee, MD
  Indiana University Melvin and Bren Simon Comprehensive Cancer Center

• David B. Miller, MBA
  Abramson Cancer Center at the University of Pennsylvania

• Patrick J. O'Brien, MBA
  Fox Chase Cancer Center

Foundation Board of Directors

• Gena Cook / Chair
  Kaliper Health

• Heather J. Kopecky, PhD, MBA / Vice-Chair
  Korn Ferry International

• Patrick J. O'Brien, MBA / Treasurer
  Fox Chase Cancer Center

• Angelique L. Richard, PhD, RN / Secretary
  City of Hope National Medical Center

• Al B. Benson III, MD, FACP, FASCO
  Robert H. Lurie Comprehensive Cancer Center of Northwestern University

• Patrick Delaney
  NCCN Foundation

• Crystal S. Denlinger, MD
  National Comprehensive Cancer Network

• Denise Portner
  SteegeThomson Communications

• Christopher Price
  Epilog Partners, LP

• Marc Samuels, JD, MPH
  ADVI

• Susan Stein, MPH
  SCS Health Solutions

• John W. Sweetenham, MD, FACP, FRCP, FASCO
  Retired

• Tamar Thompson
  Alexion AstraZeneca Rare Disease

NCCN Senior Management Team

• Crystal S. Denlinger, MD, is the Chief Executive Officer (CEO) at the National Comprehensive Cancer Network (NCCN). She joined NCCN in April 2021 as Senior Vice President, Chief Scientific Officer and was successfully recruited as CEO in 2023, following a national search. Dr. Denlinger oversees all NCCN programs and activities, including maintaining the library of NCCN Guidelines^® and advancing global collaborations, new oncology research, peer-reviewed publication, patient information, and cancer policy. 
  
  Prior to joining NCCN, Dr. Denlinger held several leadership positions with Fox Chase Cancer Center—an NCCN Member Institution—including Chief, Gastrointestinal Medical Oncology; Deputy Director, Early Drug Development Phase 1 Program; Director, Survivorship Program; and Associate Professor, Department of Hematology/Oncology. After joining NCCN, she will continue to see patients at Fox Chase Cancer Center in a limited, volunteer capacity.
  
  Dr. Denlinger has been involved with NCCN for many years, including serving as chair of the NCCN Guidelines Panel for Survivorship and serving on a number of panels, including the Esophageal/Gastric Cancers Panel, the JNCCN—Journal of the National Comprehensive Cancer Network Editorial Board, and on various abstract committees and ORP RFP committees, including chairing two committees. She was named an NCCN Young Investigator Awardee in 2012 and received the NCCN Rodger Winn Award in 2018 for exemplifying leadership, drive, and commitment in service to developing clinical practice guidelines.
   
  She graduated from a combined BS/MD program at The College of New Jersey and Rutgers New Jersey Medical School, followed by an internal medicine residency with Mount Sinai Medical Center, and hematology/oncology fellowship at Fox Chase Cancer Center/Temple University Hospital. She has authored hundreds of clinical research articles and abstracts and received awards from organizations that include the American Society of Clinical Oncology (ASCO) Foundation and the American College of Physicians.
• 

  Gary J. Weyhmuller, MBA, SPHR, is Executive Vice President/Chief Operating Officer at the National Comprehensive Cancer Network (NCCN). He joined NCCN in February 2014.
  Working closely with the CEO, he is responsible for providing leadership and management to NCCN Staff, helping to assure the development of new programs, as well as the continued efficient and effective operations of existing programs for NCCN Member Institutions and other constituencies.
  
  Gary comes to NCCN with more than 35 years of experience at Fox Chase Cancer Center, most recently serving as Senior Vice President and Chief Operating Officer, responsible for leadership and oversight of the daily operations supporting all research, clinical, and operational activities for more than 2,400 employees. Prior to this role as SVP/COO, Gary held several other leadership roles within Fox Chase, including Vice President of Human Resources and Chief Administrative Officer.
  
  Gary holds a Master of Business Administration from LaSalle University and a Bachelor of Science in education, political science, and minority studies from West Chester University. He also holds a certification as Senior Professional in Human Resources (SPHR) from Villanova University. Outside of his professional career Gary demonstrates an active history of community service. Currently he is Chair of the Board of Directors for American Heritage Federal Credit Union and was a past member of the Board of Directors for United Cerebral Palsy of Philadelphia and Vicinity, where he served as President of the Board from 2008 through 2011.
  
  Gary has been active in a number of professional organizations including the Healthcare Financial Management Association (HFMA), the American Hospital Association (AHA), the Association of American Cancer Institutes (AACI), and the Society for Human Resource Management (SHRM). He has been recognized for his leadership, both professionally and through his community service, including the Fox Chase Cancer Center Inspired Leadership Award, recognition for leadership and personal dedication on behalf of people with disabilities from United Cerebral Palsy of Philadelphia and Vicinity, and the Greater Northeast Philadelphia Chamber of Commerce Crystal Vision Award.

• Wui-Jin Koh, MD, is the Senior Vice President/Chief Medical Officer at the National Comprehensive Cancer Network (NCCN). In this role, he helps oversee the flagship NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines^®) program. In addition, he is responsible for medical leadership and oversight for NCCN’s continuing medical education program and JNCCN — Journal of the National Comprehensive Cancer Network, and represents the organization at clinical and scientific meetings.  He is also actively involved in the NCCN Global initiatives.
  
  Prior to joining NCCN in 2018, he served as Professor of Radiation Oncology at University of Washington and Medical Director for Radiation Oncology at Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance.
  
  Dr. Koh earned his medical degree at Loma Linda University School of Medicine. He conducted his post-graduate training at the University of Washington Medical Center, completing a residency in radiation oncology and a clinical fellowship in metabolic tumor imaging. He is board-certified in radiation oncology. 
  
  Dr. Koh’s research interests include combined chemo-radiation strategies, cancer management guidelines development, and the role of imaging in radiotherapy and cancer care. He specialized in the management of gynecologic and gastrointestinal tract tumors and the use of brachytherapy and intraoperative radiotherapy. He has received multiple Educator and National Top Doctors awards.
  
  Dr. Koh is well-published and involved in numerous professional societies, including the Society of Gynecologic Oncology, the American Society of Clinical Oncology, the NRG-Oncology Clinical Trials Cooperative Group, the Western Association of Gynecologic Oncology, and the International Gynecologic Cancer Society. He also served as a member of the NCI Gynecologic Cancer Steering Committee from 2007-2015.
• Eileen C. Boscia, CPA, MBA, is Vice President, Chief Financial Officer at the National Comprehensive Cancer Network (NCCN). Ms. Boscia joined NCCN in 2009 and is responsible for all aspects of financial accountability for NCCN and the NCCN Foundation including receivables, payables, financial reporting, internal controls, cash and investment management, and coordination of year-end audits for NCCN and NCCN Foundation. She is also responsible for risk management and compliance as well as review of legal, financial and other business issues concerning NCCN and the NCCN Foundation. She is responsible for providing financial and other analyses for strategic planning purposes. 
   
  Prior to working with NCCN, Ms. Boscia worked with a regional accounting firm performing audit, tax, accounting, and consulting services for small to mid-sized clients in a variety of industries including not-for-profits. She is a member of both the American Institution of Certified Public Accountants (AICPA) and the Pennsylvania Institute of Certified Public Accountants (PICPA).
   
  Ms. Boscia has a Bachelor of Science in Accounting from the University of Delaware and a Master of Business Administration with a concentration in Management Information Systems from LaSalle University. She is also licensed as a Certified Public Accountant in Pennsylvania.
• 

  Kristina M. Gregory, RN, MSN, is Senior Vice President of Clinical Information Programs at the National Comprehensive Cancer Network (NCCN). In this role, Ms. Gregory is responsible for the overall operations of the NCCN Guidelines Program.
  
  Prior to working with NCCN, Ms. Gregory served as a Health Management Program Coordinator at Independence Blue Cross and was also a staff nurse at Fox Chase Cancer Center.
  
  Ms. Gregory has a Master’s in Public Health Nursing from LaSalle University and a Bachelor of Science in Nursing from the University of Pennsylvania.

• Jennifer Tredwell, MBA, is Senior Vice President of Marketing & Communications at NCCN. In this role, Ms. Tredwell is responsible for the NCCN brand, website content, and strategic marketing plans of all programs and projects. She develops marketing and branding strategies for NCCN events, resources, publications, mobile apps, online learning, and research programs. She oversees the production of multi-channel digital and traditional marketing campaigns and is responsible for fundraising in the areas of sponsorships, exhibits, and advertising.
  
  Prior to joining NCCN as full-time employee in 2005, Ms. Tredwell consulted for NCCN as well as a number of other health care organizations, including The Children’s Hospital of Philadelphia, Albert Einstein Healthcare Network, Moss Rehab, Beebe Medical Center, and The National Spine Network. She also worked for OneBeacon Insurance where she held a range of responsibilities in marketing and communications.
  
  Ms. Tredwell received a Master of Business Administration from Temple University and a Bachelor of Arts from Syracuse University.
• Beth Gaffney, MBA, is Vice President of U.S. and Global Business Development at NCCN. In this role, Ms. Gaffney oversees both U.S. and global business activities and the development of the NCCN brand worldwide. She helps ensure the influence of NCCN content and the ongoing collaboration and support of all stakeholders. She leads multiple functional areas across the organization, including business development (U.S. and global), business insights, commercial licensing, health information technology collaborations, and payer and employer outreach. She also works closely with NCCN’s marketing and communications department and oncology policy program.
  
  Prior to joining NCCN, Ms. Gaffney led strategic business development for risk management and patient support services for United BioSource LLC. She also previously held positions with Johnson & Johnson’s McNeil Consumer Healthcare division and Men’s Health Magazine.
  
  Ms. Gaffney received a Master of Business Administration from The Wharton School of the University of Pennsylvania and a Bachelor of Arts in International Relations from St. Joseph’s University. 
• Alyssa Schatz, MSW, (she/her) serves as the Vice President of Policy and Advocacy at NCCN. In this role, Ms. Schatz is responsible for oversight of the Policy and Advocacy Department and is the primary point of contact for policymakers and regulators. The Policy and Advocacy team works to advance NCCN’s mission in health policy realms through policy engagement, stakeholder engagement, and strategic partnerships.
  
  Prior to joining NCCN, Ms. Schatz spent more than a decade in behavioral health and disability rights advocacy on behalf of peer led-organizations and provider associations. Ms. Schatz was involved in securing Medicaid expansion in Pennsylvania and advocating for the implementation of behavioral health parity rights. Ms. Schatz received a Master of Social Work with a concentration in Macro Practice from the University of Pennsylvania School of Social Policy and Practice and a Bachelor of Arts in Social Work from the Eastern Connecticut State University School of Social Work. Ms. Schatz is a Doctor of Public Health candidate at the UNC Gillings School of Global Public Health.